Index/Topics/Vaccine-induced immune thrombotic thrombocytopenia (VITT) in 2021

Vaccine-induced immune thrombotic thrombocytopenia (VITT) in 2021

Regulators worldwide reacted to reports of vaccine-induced immune thrombotic thrombocytopenia (VITT) in 2021 with emergency pauses, focused safety reviews, and revised guidance that balanced the rare risk of VITT against the substantial harms of COVID-19.